Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Feb 21, 2017; 23(7): 1233-1240
Published online Feb 21, 2017. doi: 10.3748/wjg.v23.i7.1233
Table 1 Patient clinical and pathological characteristics n (%)
Clinical variableGroup A (n = 10)Group B (n = 10)P value
mean age (yr)68 (41-79)60 (30-73)0.150
Male6 (60)4 (40)0.625
pT stage1.000
pT36 (60)6 (60)
pT44 (40)4 (40)
pN stage0.168
pN001 (10)
pN103 (30)
pN24 (40)6 (60)
Location1.000
Right colon4 (40)4 (40)
Left colon/rectum6 (60)6 (60)
Histology differentiation1.000
Well2 (20)2 (20)
Moderately4 (40)4 (40)
Poorly/mucinous4 (40)4 (40)
Lymphovascular invasion6 (60)4 (40)0.625
Preoperative CEA (median, range)1.74 (1.18-11.0)9.64 (1.12-512.9)0.017
Table 2 Analyses of serum levels of factors between group A and group B in tumor drainage and peripheral veins
Drainage blood
Peripheral blood
Group A (non-metastatic)Group B (metastatic)P valueGroup A (non-metastatic)Group B (metastatic)P value
RANTES (ng/mL)52.61 ± 35.3795.17 ± 70.210.10436.34 ± 23.6466.60 ± 25.550.013
EGF (pg/mL)150.09 ± 70.40270.67 ± 163.700.053135.16 ± 67.01289.36 ± 147.240.007
PDGFAA (ng/mL)2.30 ± 0.804.62 ± 1.600.0012.38 ± 0.853.99 ± 1.460.007
HER2 (ng/mL)2.54 ± 0.682.95 ± 1.020.2962.01 ± 0.552.91 ± 0.490.001
MMP7 (ng/mL)2.77 ± 1.474.57 ± 2.700.0802.20 ± 1.083.98 ± 2.100.028
Table 3 Correlation between factor levels in peripheral and tumor drainage venous blood
CorrelationrP value
dPDGFAA-pPDGFAA0.794< 0.001
dHER2-pHER20.1890.424
dRANTES-pRANTES0.7050.001
dEGF-pEGF0.6050.005
dMMP7-mMMP70.863< 0.001
pEGF-dPDGFAA0.6780.001
pEGF-pPDGFAA0.887< 0.001
pEGF-pHER20.4890.029
pHER2-pMMP70.5290.016